Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 4 (April)

1. Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion.
   Acta Haematol, 113(2): 146-9. [Abstract] [Full-text]
2. Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin.
   Acta Haematol, 113(2): 130-6. [Abstract] [Full-text]
3. Persistent fetal hemoglobin in maternal circulation complicating the diagnosis of fetomaternal hemorrhage.
   Obstet Gynecol, 105(4): 872-4. [Abstract] [Full-text]
4. A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders.
   Br J Haematol, 129(1): 110-7. [Abstract] [Full-text]
5. Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi.
   Eur J Clin Nutr, 59(4): 526-32. [Abstract] [Full-text]
6. Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU.
   Blood, 105(8): 3322-9. [Abstract] [Full-text]
7. Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia.
   Blood, 105(8): 3340-5. [Abstract] [Full-text]
8. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.
   Ann Hematol, 84(5): 282-6. [Abstract] [Full-text]
9. Heterozygous beta-thalassemia and homozygous H63D hemochromatosis in a child: an 18-year follow-up.
   Pediatr Hematol Oncol, 22(2): 163-6. [Abstract] [Full-text]
10. Interferon therapy in congenital dyserythropoietic anemia type I/II.
    Pediatr Hematol Oncol, 22(2): 133-8. [Abstract] [Full-text]
11. Craving for ice and iron-deficiency anemia: a case series from Oman.
    Pediatr Hematol Oncol, 22(2): 127-31. [Abstract] [Full-text]
12. The economic burden of anemia in cancer patients receiving chemotherapy.
    Value Health, 8(2): 149-56. [Abstract] [Full-text]
13. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.
    Value Health, 8(2): 105-16. [Abstract] [Full-text]
14. Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese beta-thalassemia mutations.
    Am J Hematol, 78(4): 249-55. [Abstract] [Full-text]
15. Intravenous iron in a primary-care clinic.
    Am J Hematol, 78(4): 261-4. [Abstract] [Full-text]
16. Successful treatment of Diamond-Blackfan anemia with metoclopramide.
    Am J Hematol, 78(4): 295-8. [Abstract] [Full-text]
17. Therapeutic use of quercetin in the control of infection and anemia associated with visceral leishmaniasis.
    Free Radic Biol Med, 38(9): 1257-64. [Abstract] [Full-text]
18. Frequency of glucose-6-phosphate dehydrogenase deficiency in some ethnic groups of Pakistan.
    J Coll Physicians Surg Pak, 15(3): 137-41. [Abstract] [Full-text]
19. The polymorphisms -318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population.
    Bone Marrow Transplant, 35: S89-92. [Abstract] [Full-text]
20. Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.
    Bone Marrow Transplant, 35: S17-21. [Abstract] [Full-text]
21. Stem cell transplantation for aplastic anemia and myelodysplastic syndrome.
    Bone Marrow Transplant, 35: S13-6. [Abstract] [Full-text]
22. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
    J Natl Cancer Inst, 97(7): 489-98. [Abstract] [Full-text]
23. Nutritional status and energy expenditure in children pre-bone-marrow-transplant.
    Bone Marrow Transplant, 35(8): 775-9. [Abstract] [Full-text]
24. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
    Bone Marrow Transplant, 35(8): 755-61. [Abstract] [Full-text]
25. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
    N Engl J Med, 352(14): 1413-24. [Abstract] [Full-text]
26. Hypoxia and anemia: effects on tumor biology and treatment resistance.
    Transfus Clin Biol, 12(1): 5-10. [Abstract] [Full-text]
27. Use of rituximab to treat refractory Diamond-Blackfan anemia.
    Eur J Haematol, 74(5): 442-4. [Abstract] [Full-text]
28. Comparison of DXA, QCT and trabecular structure in beta-thalassaemia.
    Eur J Haematol, 74(5): 430-7. [Abstract] [Full-text]
29. Band 3Tambaú: a de novo mutation in the AE1 gene associated with hereditary spherocytosis. Implications for anion exchange and insertion into the red blood cell membrane.
    Eur J Haematol, 74(5): 396-401. [Abstract] [Full-text]
30. Haemoglobin and anaemia in a gender perspective: the Tromsø Study.
    Eur J Haematol, 74(5): 381-8. [Abstract] [Full-text]
31. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis.
    Eur J Haematol, 74(5): 374-80. [Abstract] [Full-text]
32. Co-inheritance of the Hb Sun Prairie mutation with a point mutation at 5'-UTR in the eastern Indian population.
    Br J Haematol, 129(2): 282-6. [Abstract] [Full-text]
33. Impact of epoetin-beta on survival of patients with lymphoproliferative malignancies: long-term follow up of a large randomized study.
    Br J Haematol, 129(2): 206-9. [Abstract] [Full-text]
34. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.
    Am J Transplant, 5(5): 1146-50. [Abstract] [Full-text]
35. Screening children for sickle cell vasculopathy: guidelines for transcranial Doppler evaluation.
    Pediatr Radiol, 35(3): 235-41. [Abstract] [Full-text]
36. Glucose-6-phosphate dehydrogenase activity in term and near-term, male African American neonates.
    Clin Chim Acta, 355(1): 113-7. [Abstract] [Full-text]
37. Soluble transferrin receptor concentration is not superior to log ferritin for evaluating erythropoiesis in adolescents with iron deficiency anemia.
    Clin Chim Acta, 355(1): 83-9. [Abstract] [Full-text]
38. Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells.
    Transfusion, 45(4): 539-44. [Abstract] [Full-text]
39. Pharmacokinetics of pulmonary manganese absorption: evidence for increased susceptibility to manganese loading in iron-deficient rats.
    Am J Physiol Lung Cell Mol Physiol, 288(5): L887-93. [Abstract] [Full-text]
40. Biochemical composition of amniotic fluid in pregnancies complicated with twin-twin transfusion syndrome.
    Fetal Diagn Ther, 20(3): 186-9. [Abstract] [Full-text]
41. Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery.
    Nephrol Dial Transplant, 20: iii33-40. [Abstract] [Full-text]
42. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
    Nephrol Dial Transplant, 20: iii3-24. [Abstract] [Full-text]
43. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
    Nephrol Dial Transplant, 20: iii25-32. [Abstract] [Full-text]
44. Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levels.
    Int J Gynecol Cancer, 15(2): 285-91. [Abstract] [Full-text]
45. Comparison of Plasmodium falciparum growth in sickle cells in low oxygen environment and candle-jar.
    Acta Trop, 94(1): 25-34. [Abstract] [Full-text]
46. Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks.
    Nephrol Dial Transplant, 20: iv9-15. [Abstract] [Full-text]
47. Follow-on biologics: challenges of the "next generation".
    Nephrol Dial Transplant, 20: iv31-36. [Abstract] [Full-text]
48. What is antibody-mediated pure red cell aplasia (PRCA)?
    Nephrol Dial Transplant, 20: iv3-8. [Abstract] [Full-text]
49. Antibody-mediated pure red cell aplasia (PRCA): ensuring future progress by collecting data from a registry.
    Nephrol Dial Transplant, 20: iv27-30. [Abstract] [Full-text]
50. Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options.
    Nephrol Dial Transplant, 20: iv23-26. [Abstract] [Full-text]
51. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures.
    Nephrol Dial Transplant, 20: iv16-22. [Abstract] [Full-text]
52. Acute isovolemic anemia impairs central processing as determined by P300 latency.
    Clin Neurophysiol, 116(5): 1028-32. [Abstract] [Full-text]
53. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia.
    Nephrol Dial Transplant, 20(5): 936-44. [Abstract] [Full-text]
54. The impact of anaemia and kidney function in congestive heart failure and preserved systolic function.
    Nephrol Dial Transplant, 20(5): 915-9. [Abstract] [Full-text]
55. Unusual causes of abdominal pain: sickle cell anemia.
    Best Pract Res Clin Gastroenterol, 19(2): 297-310. [Abstract] [Full-text]
56. Parallel minisequencing followed by multiplex matrix-assisted laser desorption/ionization mass spectrometry assay for beta-thalassemia mutations.
    J Hum Genet, 50(3): 139-50. [Abstract] [Full-text]
57. The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens.
    J Infect Dis, 191(10): 1631-8. [Abstract] [Full-text]
58. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
    J Clin Oncol, 23(12): 2597-605. [Abstract] [Full-text]
59. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
    J Clin Oncol, 23(12): 2606-17. [Abstract] [Full-text]
60. Successful unrelated cord blood transplantation in a child with beta-thalassemia major.
    J Trop Pediatr, 51(2): 122-4. [Abstract] [Full-text]
61. Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey.
    Kidney Int, 67(5): 1955-60. [Abstract] [Full-text]
62. Thrombotic microangiopathy associated with the hypereosinophilic syndrome.
    Kidney Int, 67(5): 1806-11. [Abstract] [Full-text]
63. Effectiveness of biweekly versus daily iron-folic acid administration on anaemia status in preschool children.
    J Trop Pediatr, 51(2): 67-71. [Abstract] [Full-text]
64. Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis.
    Clin Chem Lab Med, 43(3): 326-31. [Abstract] [Full-text]
65. Measurement of reticulocyte and red blood cell indices in patients with iron deficiency anemia and beta-thalassemia minor.
    Clin Chem Lab Med, 43(2): 195-7. [Abstract] [Full-text]
66. Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients.
    Br J Haematol, 129(3): 435-41. [Abstract] [Full-text]
67. The impact of weekly dosing of epoetin alfa on the haematological parameters and on the quality of life of anaemic cancer patients.
    Eur J Cancer Care (Engl), 14(2): 108-12. [Abstract] [Full-text]
68. Sulfasalazine and dermatitis herpetiformis.
    Australas J Dermatol, 46(2): 101-3. [Abstract] [Full-text]
69. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
    J Thromb Haemost, 3(4): 752-62. [Abstract] [Full-text]
70. Management of anaemia in patients with breast cancer: role of epoetin.
    Ann Oncol, 16(5): 817-24. [Abstract] [Full-text]
71. A common Fanconi anemia mutation in black populations of sub-Saharan Africa.
    Blood, 105(9): 3542-4. [Abstract] [Full-text]
72. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia.
    Blood, 105(9): 3746-8. [Abstract] [Full-text]
73. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
    Biol Blood Marrow Transplant, 11(5): 349-53. [Abstract] [Full-text]
74. Individual placental territories after selective laser photocoagulation of communicating vessels in twin-twin transfusion syndrome.
    Am J Obstet Gynecol, 192(4): 1112-8. [Abstract] [Full-text]
75. Relationship between anti-ABO antibody production and hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation.
    Transplant Proc, 37(2): 1371-2. [Abstract] [Full-text]
76. Predictive factors of postrenal transplant anemia.
    Transplant Proc, 37(2): 1009-11. [Abstract] [Full-text]
77. Are anemic patients more sensitive to calcineurin inhibitors?
    Transplant Proc, 37(2): 1005-6. [Abstract] [Full-text]
78. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Transfusion, 45(5): 761-5. [Abstract] [Full-text]
79. Impact of a food-based approach to improve iron nutrition of at-risk infants in northern Canada.
    Prev Med, 40(6): 896-903. [Abstract] [Full-text]
80. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
    Exp Hematol, 33(5): 597-604. [Abstract] [Full-text]
81. Feto-feto-fetal transfusion syndrome in monozygotic monochorionic triamniotic triplets: vascular evaluation by a cast model.
    Placenta, 26(5): 432-6. [Abstract] [Full-text]
82. Use of the glycophorin A somatic mutation assay for rapid, unambiguous identification of Fanconi anemia homozygotes regardless of GPA genotype.
    Am J Med Genet A, 135(1): 59-65. [Abstract] [Full-text]
83. Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in 'normal' phenotype cells.
    Leukemia, 19(5): 862-8. [Abstract] [Full-text]
84. Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life.
    Oncology, 68: 22-32. [Abstract] [Full-text]
85. Cancer-related anemia: biological findings, clinical implications and impact on quality of life.
    Oncology, 68: 12-21. [Abstract] [Full-text]
86. Cancer-related anemia: pathogenesis, prevalence and treatment.
    Oncology, 68: 3-11. [Abstract] [Full-text]
87. Neurocognitive sequelae of sickle cell disease: current issues and future directions.
    J Pediatr Oncol Nurs, 22(3): 160-7. [Abstract] [Full-text]
88. Trends in complete blood count values during acute painful episodes in children with sickle cell disease.
    J Pediatr Oncol Nurs, 22(3): 152-9. [Abstract] [Full-text]
89. Iron deficiency with normal ferritin levels in restless legs syndrome.
    Sleep Med, 6(3): 281-2. [Abstract] [Full-text]
90. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
    Int J Clin Pract, 59(2): 163-7. [Abstract] [Full-text]
91. Cytokine mRNA expression and iron status in children living in a malaria endemic area.
    Scand J Immunol, 61(4): 370-5. [Abstract] [Full-text]
92. Postmortem molecular diagnosis of sickle beta thalassaemia.
    J Clin Pathol, 58(5): 548-9. [Abstract] [Full-text]
93. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
    J Pain Symptom Manage, 29(4): 392-400. [Abstract] [Full-text]
94. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
    Pediatr Crit Care Med, 6(3): 363-6. [Abstract] [Full-text]
95. Simultaneous occurrence of pure red cell aplasia and papular-purpuric 'gloves and socks' syndrome in parvovirus B-19 infection.
    J Eur Acad Dermatol Venereol, 19(3): 373-6. [Abstract] [Full-text]
96. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance.
    Am J Hematol, 79(1): 17-25. [Abstract] [Full-text]
97. Bone marrow embolism in sickle cell disease: a review.
    Am J Hematol, 79(1): 61-7. [Abstract] [Full-text]
98. Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia.
    Am J Hematol, 79(1): 54-7. [Abstract] [Full-text]
99. Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical study.
    J Am Soc Nephrol, 16(5): 1463-70. [Abstract] [Full-text]
100. Clinical importance of transforming growth factor-beta but not of tumor necrosis factor-alpha gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype.
     Pathobiology, 72(3): 165-70. [Abstract] [Full-text]
101. Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of eythroid progenitors.
     Transfus Med, 15(2): 125-32. [Abstract] [Full-text]
102. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates.
     J Perinatol, 25(5): 325-30. [Abstract] [Full-text]

© 2004-2008 Anemia Research Today. All Rights Reserved.